Journey Medical Corporation receives FDA approval for rosacea treatment Emrosi, meets financial guidance
From GlobeNewswire: 2025-03-26 16:01:00 Journey Medical Corporation announced FDA approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for rosacea.